Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI
NCT03297125 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2025-10-15
Summary
The purpose of this prospective, nonrandomized controlled phase IV study is to compare standard and advanced MRI for their ability to predict response to Optune therapy.
Conditions
Interventions
- DEVICE
-
Standard Magnetic Resonance Imaging (MRI)
Standard MRI.
- DEVICE
-
Advanced MRI.
Perfusion and diffusion MRI.
Sponsors & Collaborators
-
Medical College of Wisconsin
lead OTHER
Principal Investigators
-
Jennifer Connelly, MD · Medical College of Wisconsin
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-01
- Primary Completion
- 2026-01-01
- Completion
- 2026-01-01
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Advanced MRI Applications Development
NCT01847833 ·Status: UNKNOWN
-
Radiation Planning Study for High Grade Brain Tumors
NCT01191346 ·Status: COMPLETED
-
FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma
NCT01089244 ·Status: UNKNOWN
-
Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma
NCT03843814 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Human Brain Tumor Therapy Response by Magnetic Resonance (MR)
NCT00724191 ·Status: COMPLETED
-
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
NCT02843230 ·Status: COMPLETED
-
PET (FDG)-MR Imaging for the Adult Patients Presented With Brain Tumor
NCT02071017 ·Status: UNKNOWN
-
Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme
NCT01252459 ·Status: UNKNOWN ·Phase: PHASE2
-
Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients
NCT01089868 ·Status: COMPLETED
-
Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
NCT04540107 ·Status: RECRUITING ·Phase: PHASE1
-
MRI Following Stereotactic Radiosurgery (SRS) for Brain Metastases
NCT04246879 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma
NCT04143425 ·Status: COMPLETED
-
Response Assessment During MR-guided Radiation Therapy for Glioblastoma
NCT05565326 ·Status: RECRUITING
-
Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study
NCT01212731 ·Status: COMPLETED
-
Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
NCT00589095 ·Status: TERMINATED
-
uPAR-PET/MRI in Glioblastoma Multiforme
NCT02945826 ·Status: UNKNOWN ·Phase: PHASE2
-
Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
NCT02359097 ·Status: COMPLETED ·Phase: NA
-
Spectroscopic Magnetic Resonance Imaging of Glioma
NCT03677999 ·Status: WITHDRAWN
-
MR Perfusion Methods in Patients With Suspected Recurrent High Grade Gliomas
NCT02919865 ·Status: COMPLETED ·Phase: NA
-
Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma
NCT03168919 ·Status: TERMINATED ·Phase: NA
-
FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
NCT03370926 ·Status: UNKNOWN
-
MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy
NCT02031237 ·Status: COMPLETED
-
The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
NCT03242824 ·Status: COMPLETED ·Phase: PHASE2
-
Non-invasive Glioma Characterization Through Molecular Imaging
NCT03684109 ·Status: RECRUITING ·Phase: NA
-
Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
NCT06183983 ·Status: RECRUITING ·Phase: NA